Convatec announced that it received FDA approval for the delivery of a Parkinson's disease therapy through its Neria Guard ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

The components of the Eversense 365 CGM. [Image courtesy of Senseonics/Ascensia] Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

[Image taken by Sean Whooley at the American Diabetes Association’s 85th Scientific Sessions in Chicago.] The biggest names in diabetes tech gathered in Chicago this past weekend for the American ...